, Tracking Stock Market Picks
Enter Symbol:
Celgene Corporation (CELG) [hlAlert]

up 527.11 %

Celgene Corporation (CELG) upgraded to Outperform by Bernstein

Posted on: Wednesday,  Apr 22, 2009  8:25 AM ET by Bernstein

Bernstein rated Outperform Celgene Corporation (NASDAQ: CELG) on 04/22/2009, when the stock price was $19.62. Since
then, Celgene Corporation has gained 527.12% as of 01/14/2016's recent price of $123.04.
If you would have followed this Bernstein's recommendation on CELG, you would have gained 527.11% of your investment in 2458 days.

Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.

A central advantage for Bernstein clients is the ability to harness our highly regarded expertise in investment research and management. Originally known as a value investor, Bernstein has long been known for seeking out stocks with temporarily depressed prices due to unwarranted short-term pessimism about a company’s ability to recover from its current problems. This philosophy is embodied in our flagship Strategic Value portfolio. But since value and growth stocks have alternated leadership—with no clear signal of when one style will give way to the other—we’ve developed a Strategic Growth portfolio that seeks out leading companies whose stock prices don’t fully reflect their companies’ potential for superior earnings growth.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/22/2009 8:25 AM Buy
as of 12/31/2009
1 Week down  -0.62 %
1 Month up  1.04 %
3 Months up  0.23 %
1 YTD up  42.78 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2009 9:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy